Skip to content
Drug Regulatory Authority of Pakistan

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو |  English
  • facebook
  • twitter
  • envelope

Menu

  • About Us
    • DRAP at a Glance
    • Organization
    • Legislation
    • Boards and Committees
    • Quality Management System
    • Contact Us
  • Therapeutic Goods
    • Drugs
    • Medical Devices
    • Alternative Medicine
    • Controlled Substances
    • Emergency Use Authorizations
    • Clinical Trials Oversight
    • Licensing and Inspections
    • Quality Controls Labs
    • Import & Export
    • Advertisement Approvals
  • Safety Info
    • Product Recalls
    • Safety Communication
    • Safety Reporting
    • Report a Problem
  • News & Updates
    • Regulatory Updates
    • Press Releases
    • Careers
    • Tenders
    • Events
  • Publications
    • Guidelines
    • Newsletters
    • Regulatory Procedures
    • Regulatory Fees
    • Application Forms
    • Public Consultation
    • Minutes of the Meetings
  • E-Services
    • MIS Systems
    • Online Verification Services
  • Covid-19
    • News & Updates
    • COVID-19 Drugs Availability
Home > Safety Info > Product Recalls > Recall Alerts > Drug Product Recall: M/S. Gsk Pakistan Limited, Karachi issued voluntary recall of Nootropil Oral Solution (Batch No. WR7J)

Drug Product Recall: M/S. Gsk Pakistan Limited, Karachi issued voluntary recall of Nootropil Oral Solution (Batch No. WR7J)

Murtaza Awan Recall Alerts November 29, 2021February 23, 2022QA & LT

Nootropil Oral Soution (Manufactured By M/S. Gsk Pakistan Limited, Karachi)

Word FileDownload
  • ← Amendments in the Medical Devices Rules, 2017 (SRO 1500 (I) 2021)
  • Import of Short Shelf Life Material(s)/Product(s). →
  • Product Recalls
    • Recall Alerts
    • Therapeutic Products Recalls
    • Recalls and Rapid Alerts
  • Safety Communication
    • Safety Alerts
    • Health Professional Alerts
  • Safety Reporting
    • How DRAP Monitor Safety
    • How to Report Adverse Events?
    • Pharmacovigilance System
  • Report a Problem
    • COVID-19 Vaccine
    • Reporting Adverse Events
    • Product Quality Defects

Quick Navigation

Archives

Drug Regulatory Authority of Pakistan

  • Islamabad | Karachi | Lahore | Peshawar | Quetta
  • Phone: 0800-03727 (Mon to Fri 08:00AM to 04:00PM)
  • Website: www.dra.gov.pk
Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan
  • Contact Us
  • Report a Problem